Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07816978) titled 'Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Sahlgrenska University Hospital
Condition:
Pulmonary Embolism Acute
Intervention:
Drug: Reduced-dose alteplase
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: December 1, 2026
Target Sample Size: 400
Countries of Recruitment:
Denmark
Norway
Sweden
Denmark
Norway
Sweden
To know more, visit https://clinica...